Teladoc Health Reports Second-Quarter 2021 Results, Raises Full-Year Revenue Guidance

Go back to Teladoc Health Reports Second-Quarter 2021 Results, Raises Full-Year Revenue Guidance
(NYSE: TDOC) Delayed: 6.27 --0 (-0%)
Previous Close $6.27    52 Week High $22.00 
Open $6.27    52 Week Low $9.08 
Day High $6.27    P/E N/A 
Day Low $6.27    EPS $0.00 
Volume 4,262